Deviations were identified in the manufacturing process of the active substance, so it cannot be ensured that the products meet sterility specification requirements, which may pose a real threat to patients' health or life. Potential effects: infection, complications after intravenous administration, life‑threatening conditions.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from the listed batches. Check the batch number of any medicine you hold; if you have an affected batch, return it to the pharmacy and consult your doctor or pharmacist about fu...
The Chief Pharmaceutical Inspector withdrew the specified batches of Mitomycin C Kyowa from the market throughout the country and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related